Induced Hypothermia in Cardiac Arrest Patients Rescued by Extracorporeal Cardiopulmonary Resuscitation.
NCT ID: NCT00965016
Last Updated: 2009-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
45 participants
INTERVENTIONAL
2009-01-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Method:
The patients were recruited into the ECPR group only if they:
1. in cardiac arrest that necessitated external or open-chest cardiac massage and a large amount of epinephrine (\>5 mg) during CPR.
2. Could not be returned to spontaneous circulation within 10 to 20 min. After ECPR, the body temperature was started to be cooled down. Within 3 hours, the patients have been well studied to search for potential reason of CPR. If the patients have no heart problem or only intervention needed, they can be grouped into 1. Group 2 is the group, which some further operation must be delivered. Group 3 is the group who cannot afford to receive hypothermia (The physician in charge don't agree the trial.) In ECMO-supported patients, two resulting comparisons were of concern: 1) ECMO weaning versus nonweaning and 2) survival-to-discharge versus in-hospital death. We attempted to identify the risk factors that affected weaning and survival, and we analyzed the effect of ECPR with hypothermia on survival.
Expected result:
We will prove ECPR with hypothermia is a perfect strategy. And within three groups of the patients, ECMO +induced hypothermia will be the most optimal choice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Therapeutic Hypothermia Using External and Internal Cooling for Post-Cardiac Arrest Patients
NCT00827957
Multicenter Registry Study With Therapeutic Hypothermia After Cardiac Arrest in Japan
NCT00901134
Core Temperature in Patients With OHCA
NCT04976712
A Prospective Analysis of the Effect of Therapeutic Hypothermia After Cardiac Arrest
NCT00676598
Benefit of Hypothermia in OHCA Complicating AMI
NCT06141252
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Decrease temperature in 0.9℃/hour
* CVP monitoring
* the infusions were temporarily stopped if CVP increased \> 5 mm Hg over 5 mins.
* Continuous temperature monitoring with a rectal probe or bladder catheter
* One must be vigilant to avoid k+, Ma2+, and P depletion during and immediately after the infusion, particularly given the increased risk of cardiac arrhythmia that occurs with induced hypothermia.
* An evaluation of neurologic status
* IV Dormicum (midazolam 2 to 5 mg或0.125 mg/kg/hr initially) and fentanyl (0.002 mg/kg/hr initially), Pavulon (pancuronium 0.1 mg/kg) every 2 hours for a total of 32 hours.
* ABG values were used to adjust the ventilator to maintain PaO2\>100 mm Hg and PaCO2\<40 mm Hg.
* MAP: 90 \~ 100 mm Hg
* Lidocaine bolus (1 mg/kg) followed by an infusion (2 mg/min for 24 hours)
* K+\> 4.0 mmol/L
* RI infusion \< 180 mg/deciliter (10 mmol per liter)
* Antibiotics with β-lactam;Aspirin
* The temperature was maintained at 33℃ for 24 hours from the start of cooling, followed by passive rewarming, which we expected would occur over a period of 8 hours, followed by active rewarming.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No Hypothermia, No intervention, ECMO
No hypothermia used during ECPR
hypothermia
Core temperature --\> 34.9℃ within 30 min --\> 33.5℃ within 120min --\> 33℃for 24 H Decrease temperature in 0.9℃/hour
Hypothermia, intervention, ECMO
Hypothermia + intervention
hypothermia
Core temperature --\> 34.9℃ within 30 min --\> 33.5℃ within 120min --\> 33℃for 24 H Decrease temperature in 0.9℃/hour
Hypothermia, no intervention, ECMO
Hypothermia without intervention after ECMO
hypothermia
Core temperature --\> 34.9℃ within 30 min --\> 33.5℃ within 120min --\> 33℃for 24 H Decrease temperature in 0.9℃/hour
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hypothermia
Core temperature --\> 34.9℃ within 30 min --\> 33.5℃ within 120min --\> 33℃for 24 H Decrease temperature in 0.9℃/hour
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. Could not be returned to spontaneous circulation within 10 to 20 min
Exclusion Criteria
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Min-Sheng General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Min-Sheng General Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shaojung Li, physician
Role: PRINCIPAL_INVESTIGATOR
Director, department of cardiovascular surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Min-sheng General Hospital
Taoyuan District, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yao, Physician
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MSEIRB0980106
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.